January 13, 2012

Bristol-Myers Squibb has officially launched its tender offer for Inhibitex, the drug maker said Friday.

January 13, 2012

The California State Senate Health Committee on Wednesday tabled a bill that would require a prescription for the purchase of a pseudoephedrine product, exempting children's liquid formulations.

January 13, 2012

MagnaCare, a health plan management company, on Thursday announced its partnership with Telcare on that company's new wireless-enabled blood glucose meter.

January 13, 2012

British retail pharmacy chain Lloyds Pharmacy and U.S.-based Proteus Biochemical are collaborating to launch a digital health product that combines sensor-enabled tablets, a sensor patch and a mobile health application to help people with complex medication regimens and health issues.

January 12, 2012

Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

January 12, 2012

Roche on Wednesday announced it has received clearance from the Food and Drug Administration for its Accu-Chek Nano SmartView blood-glucose monitoring system.

January 11, 2012

A special focus on its diabetes franchise will define Amylin Pharmaceuticals' corporate strategy, the company's chief executive said at a recent conference sponsored by J.P. Morgan.

January 11, 2012

Fleming Pharmaceuticals has sold rights of several of its products to Valeant International, Fleming said Wednesday.

January 10, 2012

CVS Caremark's chief healthcare strategy officer on Tuesday outlined how the company's integrated pharmacy-based program for such chronic diseases as diabetes, called Pharmacy Advisor, increased medication adherence rates and physician initiation of prescriptions for concomitant medications to improve patient health.

January 10, 2012

Nicotine replacement therapies designed to help people stop smoking, specifically nicotine patches and nicotine gum, do not appear to be effective in helping smokers quit long-term, even when combined with smoking-cessation counseling, according to a new survey by researchers at Harvard School of Public Health and the University of Massachusetts Boston posted in an advance online edition of Tobacco Control Monday.

January 10, 2012

Generic drug maker Hospira has enrolled the first patient in a late-stage clinical trial of a biosimilar drug for treating kidney disease.

January 10, 2012

La Roche-Posay is launching in March its new Rosaliac AR Intense Localized Redness Intensive Care, which reduces visible redness and irritation, and is suitable for rosacea-prone skin.

January 10, 2012

Over the past year, store-brand sales of over-the-counter products have helped maintain a slight growth through the sector, and with the number of proposed prescription-to-OTC switches on the horizon, the future looks especially bright, Joe Papa, Perrigo chairman, president and CEO, told attendees of the 30th Annual J.P. Morgan Healthcare Conference held Monday.

January 10, 2012

Shire has acquired U.S. rights to a drug used to treat chronic constipation in women from Johnson & Johnson, the company said Tuesday.

January 10, 2012

Winn-Dixie on Tuesday joined the Diabetes Prevention and Control Alliance, an initiative aimed at tipping the scales against the epidemic of diabetes, prediabetes and obesity by expanding access to community-based programs that use evidence-based approaches to help prevent and control diabetes.

January 9, 2012

A CVS Caremark study found that the company's integrated pharmacy-based program — Pharmacy Advisor — increased medication adherence rates and physician initiation of prescriptions for concomitant medications, improving care for diabetes patients and resulting in savings for health plans, the company announced on Monday.

January 9, 2012

Endo Pharmaceuticals announced a short-term supply constraint of analgesic products, including Opana ER, due to the temporary shutdown of a manufacturing facility operated by Novartis Consumer Health.

January 9, 2012

Drug maker Perrigo is buying a privately owned distributor of diabetes products, the company said Monday.

January 9, 2012

Many patients that are at risk of Type 2 diabetes don't believe they require lifestyle counseling to help them curb their chance of developing the disease, according to new research published in the journal Diabetes Care.

January 6, 2012

The Food and Drug Administration has granted fast-track designation to a drug currently under development by Achillion Pharmaceuticals for hepatitis C, the company said.

January 6, 2012

Sandoz has launched a shampoo used to treat severe scalp psoriasis, the generic drug maker said.

January 6, 2012

Low levels of vitamin D have been linked to depression, according to UT Southwestern Medical Center psychiatrists working with the Cooper Center Longitudinal Study in a release issued Thursday.

January 6, 2012

It's been a big week for Walgreens. Following its exit from Express Scripts' pharmacy network, the pharmacy retailer introduced a new program to help patients either keep their pharmacy home at Walgreens or to help transition them to a new pharmacy. Why help transition customers to the competition? Because it's the right thing to do. As Greg Wasson told DSN editor Rob Eder in an exclusive interview, "our No. 1 priority is to take care of patients."

January 5, 2012

Biogen Idec and Isis Pharmaceuticals will work together on a drug invented by Isis for spinal muscular atrophy, the two companies said.